Eli Lilly’s Alzheimer’s drug approved in Japan
Japan’s Ministry of Health has approved Eli Lilly’s Alzheimer’s drug donanemab, giving patients another treatment option after Eisai and Biogen’s Leqembi received the go-ahead in September last year.
POPULAR POSTS
Earthquakes and emissions undermine the idea of carbon storage in Texas
December 17, 2024
Rescuers search for cyclone survivors in devastated Mayotte
December 17, 2024
“Gilmore Girls” airs for a second season on Hulu
December 17, 2024
LIVE STREAM